Molecular Characterization of Moraxella Catarrhalis From Pneumonic Children at Pediatric Assiut University Hospital
NCT06357507 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 90
Last updated 2024-04-16
Summary
moraxella catarrhalis is responsible for respiratory tract infection in children and adults with streptococcus pneumonia and haemophilus influenza.Moraxella catarrhalis is gram negative diplococci, non-motile and non spore bearing bacteria. Until, 1995 it was considered as a non pathogenic respiratory tract flora.This bacteria is an important pathogen and a common cause of both upper and lower respiratory tract infections, pneumonia, sinusitis and conjunctivitis in infants, children and in elderly patients. In adults, M. catarrhalis also causes chronic obstructive pulmonary disease (COPD) and pneumonia. However, it is associated with a number of respiratory infections affecting both children and adults, including laryngitis, bronchitis and pneumonia .
Conditions
- Respiratory Tract Infections
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 1 Month
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-12-01
- Primary Completion
- 2027-12-01
- Completion
- 2027-12-20
More Related Trials
-
Treatment of Macrolide-resistant Mycoplasma Pneumoniae
NCT03530319 ·Status: UNKNOWN ·Phase: NA
-
The Optimization of Mycoplasm Pneumonia Antibiotic Therapy
NCT01259141 ·Status: COMPLETED ·Phase: NA
-
Moxifloxacin Versus Amoxicillin Clavulanic Acid in Treatment of Acute Exacerbation of Chronic Bronchitis
NCT00656747 ·Status: COMPLETED ·Phase: PHASE4
-
Middle Meatal Bacteriology During Acute Respiratory Infection in Children
NCT00545961 ·Status: UNKNOWN ·Phase: PHASE4
-
Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children
NCT05026749 ·Status: RECRUITING ·Phase: PHASE3
-
Four Months Moxifloxacin Containing Daily Regimen Study Among New Pulmonary Tuberculosis Patients
NCT05047055 ·Status: ACTIVE_NOT_RECRUITING
-
Safety and Efficacy of DSM 32444 Postbiotic in the Treatment of Acute Rhinosinusitis
NCT05999955 ·Status: COMPLETED ·Phase: NA
-
Macrolides in COPD- Bronchiectasis Overlap
NCT04215172 ·Status: UNKNOWN
-
Improving Antibiotic Prescribing for Pediatric Respiratory Infections by Family Physicians With Peer Comparison
NCT04588376 ·Status: COMPLETED ·Phase: NA
-
Azithromycin to Prevent Wheezing Following Severe Respiratory Syncytial Virus (RSV) Bronchiolitis
NCT01486758 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Pilot Clinical Trial of Azithromycin Treatment In Respiratory Syncytial Virus (RSV)- Induced Respiratory Failure In Children
NCT02707523 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment and Vaccine Development of Mycoplasma Pneumoniae
NCT03911440 ·Status: UNKNOWN ·Phase: NA
-
Effects of Oral Steroid in Mycoplasma Pneumoniae Pneumonia
NCT02618057 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of Macrolide Immunomodulation in Severe Sepsis.
NCT00708799 ·Status: TERMINATED ·Phase: PHASE2
-
Clinical Study on the Early Bactericidal Activity of Sitafloxacin Against Mycobacterium Abscessus Disease
NCT06809413 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
A Study to Assess the Efficacy and Safety of IV/PO Moxifloxacin in Subjects With Community-acquired Pneumonia
NCT00717561 ·Status: COMPLETED ·Phase: PHASE3
-
An Open Label Trial of Azithromycin in Chronic Productive Cough
NCT02196493 ·Status: UNKNOWN ·Phase: PHASE3
-
Impact of Reducing Colistin Use on Colistin Resistance in Humans and Poultry in Indonesia
NCT05960084 ·Status: UNKNOWN
-
Efficacy of Azithromycin in Treatment of Bronchiectasis
NCT02107274 ·Status: COMPLETED ·Phase: PHASE4
-
Xiyanping Injection Combined With Azithromycin VS Azithromycin for Children With pneumoniaProtozoal Pneumonia
NCT04296383 ·Status: UNKNOWN ·Phase: NA
-
Moxifloxacin in Pediatric Subjects With Complicated Intra-abdominal Infection
NCT01069900 ·Status: COMPLETED ·Phase: PHASE3
-
Population Pharmacokinetics of Cephalosporins and Macrolides in Chinese Children With Community Acquired Pneumonia
NCT02775968 ·Status: UNKNOWN
-
Macrolide Azithromycin to Prevent Rapid Worsening of Symptoms Associated With Chronic Obstructive Pulmonary Disease
NCT00325897 ·Status: COMPLETED ·Phase: NA
-
Dexlansoprazole MR-Based Concomitant Quadruple Therapy
NCT03829150 ·Status: COMPLETED ·Phase: NA
-
Azithromycin to Prevent Wheezing Following Severe RSV Bronchiolitis-II
NCT02911935 ·Status: COMPLETED ·Phase: PHASE2/PHASE3